The MS Barometer is a comparative MS survey of the national situation in up to 34 European countries. See how Ireland compares to other countries in a variety of areas including access to treatments, employment and empowerment of people with Multiple Sclerosis.
New centrally managed funding system established for Natalizumab (Tysabri) and Alemtuzumab (Lemtrada)
A new incidence study on MS in the Republic of Ireland has been published. The study, carried out by staff from St Vincent’s Hospital Dublin, was performed to ascertain all new cases of MS diagnosed from 1st March 2014 – 28th February 2015.
We are pleased to announce that MS Ireland is listed on The Governance Code Register of Compliance
This week Niamh McCarron writes about MS, music festivals, camping, muddy fields and shares some festival survival tips!
Last month Emma Rogan started a conversation about having MS and money. What impact did being diagnosed with MS have on her finances and outlook? This week she’s full on with her own financial planning, revealing the steps that are making a difference, financially speaking, to her life.
© 2010 - 2024 Multiple Sclerosis Society of Ireland